Caricamento...
Ixazomib promotes CHOP-dependent DR5 induction and apoptosis in colorectal cancer cells
Background: Ixazomib (Ninlaro), a novel proteasome inhibitor, has been developed for the treatment of many cancers and has demonstrated anti-tumor efficacy against various malignancies. However, the mechanism of the anti-tumor effect of ixazomib in colorectal cancer (CRC) cells remains unclear. Meth...
Salvato in:
| Pubblicato in: | Cancer Biol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370389/ https://ncbi.nlm.nih.gov/pubmed/30359552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529095 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|